|
|
Article: New Data Confirm Pramipexole (Mirapexin(R)/Sifrol(R)) Can Significantly Reduce Sleep Disturbance for People With Restless Legs Syndrome (RLS).
- Article from:
- PR Newswire Europe
- Article date:
- April 17, 2008
|
Copyright informationCOPYRIGHT 2008 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
INGELHEIM, Germany, April 17 /PRNewswire/ --
- For Healthcare Media Outside the U.S.A.
- Studies Demonstrate Positive and Rapid Impact of Pramipexole on the Core Symptoms of Restless Legs Syndrome and Sleep Disturbance
A new study has shown that pramipexole (Mirapexin(R)/Sifrol(R)) can significantly reduce sleep disturbance, often the most troublesome symptom experienced by people with Restless Legs Syndrome (RLS).(1) The important finding, presented today at the 60th Annual Meeting of the American Academy of Neurology (AAN) in Chicago, U.S.A., highlights the benefit of an RLS treatment which effectively targets the core symptoms of the condition, such as an ...
Related newspaper, magazine, and journal articles:
|